Latest Industry Insights

While traditional methods of cell sorting come with several challenges, microbubbles are simple to use and can separate cells without causing harm. Technology Networks spoke to Dr. Brandon McNaughton, CEO and co-founder of Akadeum to find out more about this technology, its applications and how it could improve cancer treatment.

In this interview, John Finn tells us more about PGI, how it compares to other genome editing approaches and the benefits it could bring to genomic medicine discovery.

Encouraging scientists to rethink the materials and methods they use will help to foster a culture of sustainability within research institutions and across various industries. Technology Networks spoke with Dr. Joel Eichmann from Green Elephant Biotech to learn more about the creation of its plant-based plastic labware, and his broader vision for embedding sustainability within the biotech industry.

To find out more about AI in pharma, Technology Networks spoke with Roger Palframan, head of US Research and digital for Early Solutions at UCB.

As the use of generative AI tools expands, and their potential in scientific research is better understood, there are ethical considerations to be made. Dr. Dror Kolodkin-Gal explores some of the issues and potential solutions.

In this interview, Dr. Tabitha Bullock tells us about some of the key considerations in cell line development and how advances in technology are improving the efficiency and productivity of cell lines.

Andrew Schulman explores why we need allogeneic therapies, the importance of collaboration to keep the momentum, and challenges and predictions for the future.

Technology Networks spoke to Dr. Markus Gershater to learn more about Synthace's Lab automation & experimentation in life science R&D 2023-2024 report, its findings and their significance.

Technology Networks spoke to the CEO of the Novo Nordisk Foundation Cellerator, Dr. Thomas H.R. Carlsen, to find out more about their new world-class facility that will focus on upscaling cell therapy development.

With growing sustainability demands, companies are looking for ways to demonstrate their green credentials. We spoke to Dr. Michael Frank to find out what ACT accreditation means for a company and why he thinks schemes like this are so important.